# PMV Pharmaceuticals, Inc.: Form 8-K, filed Mar 1, 2023

- Company: [PMV Pharmaceuticals, Inc.](/companies/pmvp.md) (CIK 1699382)
- Form: 8-K
- Filed: 2023-03-01
- Accepted by EDGAR: Mar 1, 2023, 13:01 ET
- Period: 2023-03-01
- Accession: 0000950170-23-005343
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1699382/000095017023005343/pmvp-20230301.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1699382/000095017023005343/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1699382/000095017023005343/pmvp-20230301.htm

Filed Mar 1, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-005343. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.